USBC, Inc. — fact timeline

USBC, Inc. incurred credit facility of $5.0 million with Payward Interactive at 8.5% per annum maturing June 1, 2027.

“drew an additional fixed-rate borrowing of $5.0 million (the "Third Draw") under its previously disclosed Master Loan Agreement with Payward Interactive (the "Lender") dated March 18, 2026 (the “MLA”), which provides for borrowings of up to $25.0 million in aggregate principal amount for up to a twelve-month term, subject to the execution of one or more individual loan term sheets. The Third Draw increases the aggregate principal amount outstanding under the MLA to $15.0 million which bears interest at a rate of 8.5% per annum maturing on June 1, 2027”

USBC, Inc. incurred credit facility of $5.0 million with Payward Interactive at 8.5% per annum maturing April 27, 2027.

“On April 27, 2026, USBC, Inc. (the “Company”) drew an additional fixed-rate borrowing of $5.0 million (the "Second Draw") under its previously disclosed Master Loan Agreement with Payward Interactive dated March 18, 2026 (the “MLA”), which provides for borrowings of up to $25.0 million in aggregate principal amount for up to a twelve-month term, subject to the execution of one or more individual loan term sheets.”

USBC, Inc. incurred loan of up to $450,000 with Particle Acquisition Corporation at ten percent (10%) per annum maturing September 23, 2026.

“On March 27, 2026, the Company and the Buyer entered into a short-term secured promissory note (the "Note") agreement in an aggregate principal sum of up to $450,000 solely to fund a portion of Buyer’s operating expenses until permanent equity financing is secured by the Buyer.”

USBC, Inc. received a nyse_american compliance regained notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

“March 27, 2026, USBC, Inc. (the "Company") received a letter from NYSE American LLC (the “NYSE American”) notifying the Company that it has regained compliance with all applicable continued listing standards set forth in Part 10 of the NYSE American Company Guide (the "Company Guide"). As previously disclosed, on September 27, 2024, the Company received notice from the NYSE American that it was not in compliance with the minimum stockholders’ equity requirements of Sections 1003(a)(i), (ii) and (iii) of the Company Guide. The Company subsequently implemented a plan to regain compliance, which”

USBC, Inc. entered into Agreement with Vast Bank, N.A. and Uphold HQ Inc. (effective 2026-01-20).

“On January 20, 2026 (the “Effective Date”), USBC, Inc. (the “Company”) entered into a strategic partnership agreement (the “Agreement”) with Vast Bank, N.A., a national banking association (“Vast Bank”) and Uphold HQ Inc., a South Carolina corporation (“Uphold”).”

USBC, Inc. amended Amended and Restated Digital Asset Management Agreement with Hyrcanian Asset Management, LLC valued at discretionary treasury management services with respect to the Company’s Bitcoin treasury strategy (effective 2025-12-12).

“On December 12, 2025, USBC, Inc. (the “Company”) entered into an Amended and Restated Digital Asset Management Agreement (the “Amended and Restated Agreement”) with Hyrcanian Asset Management, LLC (the “Manager”) to update and clarify the terms under which the Manager provides discretionary treasury management services with respect to the Company’s Bitcoin treasury strategy.”

USBC, Inc.: Certificates of withdrawal filed to terminate the designations for Series C, Series D, and Series H Convertible Preferred Stock, deleting related provisions from the Restated Articles of Incorporation (effective 2025-12-11).

“On December 11, 2025, the Company filed with the Secretary of State of the State of Nevada certificates of withdrawal to terminate the designations for the Company’s Series C Convertible Preferred Stock, Series D Convertible Preferred Stock, and Series H Convertible Preferred Stock.”

USBC, Inc.: Changed company name to USBC, Inc. via Certificate of Amendment to Articles of Incorporation (effective 2025-08-15).

“On August 6, 2025, the Company filed a Certificate of Amendment to the Company’s articles of incorporation, as amended to date, effecting the Name Change.”

USBC, Inc. completed an acquisition involving Goldeneye 1995 LLC for 1,000 Bitcoin, and $15 million in cash (closed 2025-08-06).

“stock, par value $0.001 per share (the “Common Stock”) to the Buyer, at a per Share purchase price of $0.335 in exchange for aggregate purchase price for the Shares of: (i) 1,000 Bitcoin, and (ii) $15 million in cash (together the “Purchase Price”). At its special stockholders meeting held on July 31, 2025, the Company’s stockholders approved: (i) the”

USBC, Inc.: Articles of Incorporation amended to increase authorized Common Stock from 7,500,000 to 750,000,000 shares (effective 2025-07-31).

“At the Special Meeting, the stockholders of the Company approved an amendment to the Company’s Articles of Incorporation to increase the Company’s authorized shares of Common Stock from 7,500,000 shares of Common Stock to 750,000,000 shares of Common Stock (the “Articles of Incorporation Amendment”). The Certificate of Amendment to the Articles of Incorporation Amendment was filed with the Nevada Secretary of State on July 31, 2025, and became effective on that date.”

USBC, Inc. incurred loan of up to $350,000 with Goldeneye 1995 LLC at 12% per annum maturing the earlier of (i) January 28, 2026 or (ii) demand by the Buyer.

“the Company and the Buyer entered into a Promissory Note (the "Bridge Note"), pursuant to which the Buyer has agreed to loan the Company an aggregate amount of up to $350,000 (the "Bridge Loan")”

Peter Conley was terminated as other_named_officer at USBC, Inc..

“The Conley Amendment provides that Mr. Conley’s employment term will terminate automatically upon the consummation of the transactions contemplated by Purchase Agreement.”

USBC, Inc.: Certificate of Designation for Series H Convertible Preferred Stock filed and effective (effective 2025-06-02).

“On May 30, 2025, in connection with the Conversion Agreement, the Company’s Board of Directors approved the adoption and filing of a Certificate of Designation for 30,000 shares of Series H Convertible Preferred Stock (“Series H Certificate of Designation”), a newly created classes of preferred stock. The Series H Certificate of Designation were filed and became effective with the Secretary of State of Nevada on June 2, 2025.”

USBC, Inc. received a nyse_american compliance regained notice regarding other (rules 1003(f)(v)).

“February 27, 2025, Know Labs, Inc., a Nevada corporation (the “Company”) received a notification from NYSE American LLC (“NYSE American”) informing the Company that it has resolved the continued listing deficiency with respect to low selling price as described in Section 1003(f)(v) of the NYSE American Company Guide (“Company Guide”). As a result, the staff of NYSE Regulation has withdrawn its delisting determination and will be lifting the trading suspension of the Company’s common stock on NYSE American. The common stock will commence trading on NYSE American on Wednesday, March 5, 2025 unde”

USBC, Inc.: Approved a 1-for-40 reverse stock split and filed Certificate of Change with Nevada Secretary of State, reducing authorized shares from 300,000,000 to 7,500,000 (effective 2025-02-19).

“The Board of Directors of Know Labs, Inc., a Nevada corporation (the “Company”) approved a reverse stock split of the Company’s authorized and issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”) at a ratio of 1-for-40 (the “Reverse Stock Split”). The Company filed a Certificate of Change (the “Certificate of Change”) pursuant to Nevada Revised Statutes Section 78.209 with the Secretary of State of the State of Nevada on February 10, 2025.”

USBC, Inc. received a nyse_american delisting notice notice regarding minimum bid price (rules 1003(f)(v)).

“January 29, 2025, NYSE American LLC (“ NYSE American ” or the “ Exchange ”) publicly announced and provided a notice to Know Labs, Inc. (the “ Company ”) that the NYSE Regulation has suspended trading of, and determined to commence proceedings to delist, the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), from NYSE American. NYSE Regulation has determined that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide (the “ Company Guide ”) due to the low selling price of the Common Stock. The Company has a right”

USBC, Inc. received a nyse_american delisting notice notice regarding minimum bid price (rules 1003(f)(v)).

“January 29, 2025, NYSE American LLC (“ NYSE American ” or the “ Exchange ”) publicly announced and provided a notice to Know Labs, Inc. (the “ Company ”) that the NYSE Regulation has suspended trading of, and determined”

USBC, Inc. received a nyse_american extension granted notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“December 10, 2024, Know Labs, Inc. (the “Company”) received notice from the NYSE American LLC (“NYSE American”) that it had accepted the Company’s plan to regain compliance with the NYSE American continued listing standards and granted a plan period through March 27, 2026 (“Extension Date”). As previously disclosed on September 27, 2024, the Company received a letter from the NYSE American stating that the Company was not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide, which require stockholders’ equity o”

USBC, Inc.: Amendment to Articles of Incorporation to increase authorized shares of common stock from 200 million to 300 million (effective 2024-10-29).

“The Amendment was filed with the Nevada Secretary of State on October 29, 2024, and became effective on that date.”

Timothy Londergan resigned as Director at USBC, Inc..

“On September 6, 2024, Timothy Londergan, a member of the Board of Directors of Know Labs, Inc. (the “Company”), tendered his resign from the Company's Board of Directors, effective September 6, 2024.”

USBC, Inc. entered into At the Market Offering Agreement with The Benchmark Company, LLC valued at $5,000,000 (effective 2024-03-20).

“On March 20, 2024, Know Labs, Inc. (the “Company”) entered into an At the Market Offering Agreement (the “ATM Agreement”) with The Benchmark Company, LLC (“Benchmark”), as sales agent, pursuant to which the Company may, from time to time, offer and sell shares of its common stock, par value $0.001 per share (the “Shares”), through or to Benchmark as its sales agent or manager.”

USBC, Inc. incurred convertible notes of $4,800,000 with Lind Global Fund II, LP at Notes do not carry any interest.

“issued to Lind an initial Note with an outstanding principal amount of Four Million Eight Hundred Thousand Dollars ($4,800,000) in exchange for a purchase price of Four Million Dollars ($4,000,000)”

USBC, Inc. entered into Securities Purchase Agreement with Lind Global Fund II, LP valued at $14,400,000 (effective 2024-02-27).

“On February 27, 2024, Know Labs, Inc. (the “Company”) (a) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Lind Global Fund II, LP (“Lind”), pursuant to which the Company may issue Lind one or more senior convertible notes (the “Notes”) in the aggregate principal amount of up to Fourteen Million Four Hundred Thousand Dollars ($14,400,000)”

USBC, Inc. incurred convertible notes of $4,800,000 with Lind Global Fund II, LP at no interest.

“issued to Lind an initial Note with an outstanding principal amount of Four Million Eight Hundred Thousand Dollars ($4,800,000)”

USBC, Inc. entered into Securities Purchase Agreement with Lind Global Fund II, LP valued at up to Fourteen Million Four Hundred Thousand Dollars ($14,400,000) for an aggregate purchase price e (effective 2024-02-27).

“On February 27, 2024, Know Labs, Inc. (the “Company”) (a) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Lind Global Fund II, LP (“Lind”), pursuant to which the Company may issue Lind one or more senior convertible notes (the “Notes”) in the aggregate principal amount of up to Fourteen Million Four Hundred Thousand Dollars ($14,400,000) for an aggregate purchase price equal to up to Twelve Million Dollars ($12,000,000) (the “Offering”) and Common Stock purchase warrants (the “Warrants”)”

USBC, Inc. reported first quarter ended December 31, 2023 results: net income net loss of $3.45 million dollars, EPS Earnings Per Share of a loss of $0.04.

“In Q1 FY 2024, Know Labs reported a net loss of $3.45 million dollars, compared to a net loss of $3.82 million dollars in Q1 FY 2023, a reduction in net loss of 9.8%. This translates to Earnings Per Share of a loss of $0.04, better than the prior year quarter Earnings Per Share Loss of $0.08, an improvement of 50%, before preferred stock dividends.”

Timothy M. Londergan was appointed as Director at USBC, Inc..

“On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.”

John Cronin was appointed as Director at USBC, Inc..

“On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.”

Larry K. Ellingson was appointed as Director at USBC, Inc..

“On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.”

USBC, Inc. entered into Underwriting Agreement with Boustead Securities, LLC and The Benchmark Company, LLC as representatives of the underwriters valued at approximately $6.39 million (effective 2023-09-26).

“On September 26, 2023, Know Labs, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Boustead Securities, LLC and The Benchmark Company, LLC as representatives (the “ Representatives ”) of the underwriters named on Schedule 1 thereto (the “ Underwriters ”), relating to the Company’s registered public offering (the “ Offering ”) of shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”).”

USBC, Inc. shareholders approved Approved, by a non-binding advisory vote, the frequency of 1 year for future advisory votes on the compensation of the Company's named executive officers at the 2023-09-22 meeting.

“Approved, by a non-binding advisory vote, the frequency of 1 year for future advisory votes on the compensation of the Company's named executive officers as follows One Year Two Years Three Years Abstain Broker Non-Vote 14,756,773 97,577 577,836 63,501 N/A”

USBC, Inc. shareholders approved Approved, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement at the 2023-09-22 meeting.

“Approved, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement as follows: For Against Abstain Broker Non-Vote 13,800,174 1,310,448 385,065 13,689,417”

USBC, Inc. shareholders approved Approved and ratified the appointment of BPM, LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2023 at the 2023-09-22 meeting.

“Approved and ratified the appointment of BPM, LLP of Walnut Creek, CA as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2023 as follows: For Against Abstain Broker Non-Vote 28,199,571 946,043 39,490 -”

USBC, Inc. shareholders approved Elected four nominees to serve on the Board until the 2024 Annual Meeting of Stockholders at the 2023-09-22 meeting.

“Elected four nominees to serve on the Board until the 2024 Annual Meeting of Stockholders as follows: Director Nominee For Withhold Broker Non-Vote Ronald P. Erickson 14,875,891 619,796 N/A Jon Pepper 14,242,181 1,253,506 N/A Ichiro Takesako 13,907,483 1,588,204 N/A William A. Owens 14,613,488 882,199 N/A”

USBC, Inc. amended senior secured convertible redeemable notes with Clayton Struve (effective 2023-09-15).

“On September 15, 2023, Know Labs, Inc. (the “Company”) approved the Amendments below to the senior secured convertible redeemable notes with Clayton Struve, extending the due dates from September 30, 2023 to September 30, 2024.”

USBC, Inc. reported third quarter ended June 30, 2023 results: net income net loss of $3.59 million dollars, EPS loss of $0.07.

“Know Labs reported a net loss of $3.59 million dollars in the third quarter of 2023, compared to a net loss of $3.03 million dollars in the year-ago period, which translates to Earnings Per Share of a loss of $0.07, unchanged from the year ago period of a loss of $0.07 before preferred stock dividends.”

USBC, Inc.: Filed restated articles of incorporation to correct prior unapproved amendments from 2013 annual meeting, incorporating all valid amendments prior to and after 2013 (effective 2023-08-11).

“On August 11, 2023, we filed restated articles of incorporation with the Nevada Secretary of State, which present the entire text of our Articles, as amended prior to the 2013 Annual Meeting, and as further amended by the Subsequent Amendments, but disregarding the amendments proposed in Proposal 3 at the 2013 Annual Meeting.”

Jessica English was appointed as Chief Marketing Officer at USBC, Inc..

“Jessica English, Chief Marketing Officer, 37.”

Leo Trautwein changed role as Chief Commercial Officer at USBC, Inc..

“Mr. Trautwein has held the Chief Marketing Officer title since then and now transitions to Chief Commercial Officer.”

Masanori King Takee was appointed as Chief Technology Officer at USBC, Inc..

“Masanori King Takee, Chief Technology Officer, 43.”

Ronald P. Erickson was appointed as Chief Executive Officer at USBC, Inc..

“On January 23, 2023, the Board of Directors of the Company appointed Ronald P. Erickson, the current Chairman of the Board, to the position of Chief Executive Officer of the Company.”

Phillip A. Bosua resigned as Chief Executive Officer at USBC, Inc..

“On January 23, 2023, Phillip A. Bosua resigned from the Board of Directors and from his position as Chief Executive Officer of Know Labs, Inc.”

Steven Kent was appointed as Chief Product Officer at USBC, Inc..

“Steven Kent, Chief Product Officer – Mr. Kent joins Know Labs as Chief Product Officer, where he will be responsible for product development and clinical testing.”

Peter Conley was appointed as Chief Financial Officer and SVP Intellectual Property at USBC, Inc..

“Peter Conley, Chief Financial Officer and SVP Intellectual Property (IP) – Mr. Conley brings over 34 years of corporate finance and equity capital markets experience, more than $5B in equity transactions, and over 20 years of specialization in strategic IP analysis, IP development and IP monetization to Know Labs, joining the company as Chief Financial Officer and SVP, Intellectual Property.”